| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the Department of Pediatrics, College of Medicine, University of Arkansas for Medical Sciences and Arkansas Children's Hospital Research Institute, Little Rock
Background: It is well established that folic acid prevents neural tube defects. Although the mechanisms remain unclear, multivitamins containing folic acid may also protect against other birth defects, including congenital heart defects.
Objective: Our goal was to establish a maternal metabolic risk profile for nonsyndromic congenital heart defects that would enhance current preventive strategies.
Design: Using a case-control design, we measured biomarkers of the folate-dependent methionine and homocysteine pathway among a population-based sample of women whose pregnancies were affected by congenital heart defects (224 case subjects) or unaffected by any birth defect (90 control subjects). Plasma concentrations of folic acid, homocysteine, methionine, S-adenosylmethionine (SAM), S-adenosylhomocysteine (SAH), vitamin B-12, and adenosine were compared, with control for lifestyle and sociodemographic variables.
Results: After covariate adjustment, case subjects had higher mean concentrations of homocysteine (P < 0.001) and SAH (P < 0.001) and lower mean concentrations of methionine (P = 0.019) and SAM (P = 0.014) than did control subjects. Vitamin B-12, folic acid, and adenosine concentrations did not differ significantly between case and control subjects. Homocysteine, SAH, and methionine were identified as the most important biomarkers predictive of case or control status.
Conclusions: The basis for the observed abnormal metabolic profile among women whose pregnancies were affected by congenital heart defects cannot be defined without further analysis of relevant genetic and environmental factors. Nevertheless, a metabolic profile that is predictive of congenital heart defect risk would help to refine current nutritional intervention strategies to reduce risk and may provide mechanistic clues for further experimental studies.
Key Words: Birth defects • congenital heart defects • risk • methionine • homocysteine • folate
This article has been cited by other articles:
|
|
 |
|
  L. M. J. W. van Driel, R. de Jonge, W. A. Helbing, B. D. van Zelst, J. Ottenkamp, E. A. P. Steegers, and R. P. M. Steegers-Theunissen Maternal Global Methylation Status and Risk of Congenital Heart Diseases Obstet. Gynecol., August 1, 2008; 112(2): 277 - 283. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. M.J.W. van Driel, H. P.M. Smedts, W. A. Helbing, A. Isaacs, J. Lindemans, A. G. Uitterlinden, C. M. van Duijn, J. H.M. de Vries, E. A.P. Steegers, and R. P.M. Steegers-Theunissen Eight-fold increased risk for congenital heart defects in children carrying the nicotinamide N-methyltransferase polymorphism and exposed to medicines and low nicotinamide Eur. Heart J., June 1, 2008; 29(11): 1424 - 1431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Malik, M. A. Cleves, M. A. Honein, P. A. Romitti, L. D. Botto, S. Yang, C. A. Hobbs, and and the National Birth Defects Prevention Study Maternal Smoking and Congenital Heart Defects Pediatrics, April 1, 2008; 121(4): e810 - e816. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Yang, S. L. Carmichael, M. Canfield, J. Song, G. M. Shaw, and the National Birth Defects Prevention Study Socioeconomic Status in Relation to Selected Birth Defects in a Large Multicentered US Case-Control Study Am. J. Epidemiol., January 15, 2008; 167(2): 145 - 154. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I.M. van Beynum, M. den Heijer, H.J. Blom, and L. Kapusta The MTHFR 677C->T polymorphism and the risk of congenital heart defects: a literature review and meta-analysis QJM, December 1, 2007; 100(12): 743 - 753. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Malik, M. A. Cleves, W. Zhao, A. Correa, C. A. Hobbs, and and the National Birth Defects Prevention Study Association Between Congenital Heart Defects and Small for Gestational Age Pediatrics, April 1, 2007; 119(4): e976 - e982. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. A. Riedijk, B. Stoll, S. Chacko, H. Schierbeek, A. L. Sunehag, J. B. van Goudoever, and D. G. Burrin Methionine transmethylation and transsulfuration in the piglet gastrointestinal tract PNAS, February 27, 2007; 104(9): 3408 - 3413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Robbins, J. M. Tilford, T.M. Bird, M. A. Cleves, J. A. Reading, and C. A. Hobbs Hospitalizations of Newborns With Folate-Sensitive Birth Defects Before and After Fortification of Foods With Folic Acid Pediatrics, September 1, 2006; 118(3): 906 - 915. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Tamura and M. F. Picciano Folate and human reproduction Am. J. Clinical Nutrition, May 1, 2006; 83(5): 993 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M. van Beynum, L. Kapusta, M. den Heijer, S. H.H.M. Vermeulen, M. Kouwenberg, O. Daniels, and H. J. Blom Maternal MTHFR 677C>T is a risk factor for congenital heart defects: effect modification by periconceptional folate supplementation Eur. Heart J., April 2, 2006; 27(8): 981 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Hobbs, S. Malik, W. Zhao, S. J. James, S. Melnyk, and M. A. Cleves Maternal Homocysteine and Congenital Heart Defects J. Am. Coll. Cardiol., February 7, 2006; 47(3): 683 - 685. [Full Text] [PDF]
|
|
|
|
|
|
C. A Hobbs, M. A Cleves, W. Zhao, S. Melnyk, and S J. James Congenital heart defects and maternal biomarkers of oxidative stress Am. J. Clinical Nutrition, September 1, 2005; 82(3): 598 - 604. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
